COVI-COMPLECT: Role of the complement lectin pathway in the pathogenesis of SARS-CoV-2 infection

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • start year

    -99
  • Known Financial Commitments (USD)

    $0
  • Funder

    ANR
  • Principal Investigator

    Nicole Thielens
  • Research Location

    France
  • Lead Research Institution

    Institut de Biologie Structurale (IBS) - CEA / Grenoble
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The COVI-COMPLECT project, coordinated by Nicole Thielens (UMR 5075 - Institut de Biologie Structurale (IBS) - CEA / Grenoble) aims to understand the role of the complement lectin pathway, a major player in innate antiviral immune defense, in the pathophysiogenesis of SARS-CoV-2 infection. He proposes to decipher the molecular mechanisms of interactions of SARS-CoV-2 proteins with components of the complement lectin pathway and to assess their functional consequences, including viral neutralization and complement activation. A better understanding of the relative roles of specific complement components, particularly those involved in the activation of the lectin pathway, would be useful in identifying possible patients at risk and in guiding potential therapy targeting the complement.